Epidemiologic Changes and Economic Burden of Hypertension in Latin America. Evidence from Mexico

American Journal of Hypertension

Volumn 19, Issue 6, 2006, Pages 553-559

  Arredondo, Armando ^a   Zúniga, Alexis ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

costs; economic burden; Epidemiologic changes; health policy

Indexed keywords

ARTICLE; BUDGET; CARDIOVASCULAR RISK; ECONOMIC ASPECT; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH SERVICE; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MEXICO; PRIORITY JOURNAL; SOUTH AND CENTRAL AMERICA;

COST OF ILLNESS; DATA INTERPRETATION, STATISTICAL; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; HYPERTENSION; INFLATION, ECONOMIC; LATIN AMERICA; LONGITUDINAL STUDIES; MEXICO; MODELS, ECONOMETRIC; RISK FACTORS; SOCIAL SECURITY;

EID: 33646837836     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2005.10.028     Document Type: Article

References (30)

1. Quentin T., and Wodon. Poverty and Policy in Latin America and the Caribbean. World Bank Technical Paper (2005) pp 53-58
2. Juárez C. La Regulación del Mercado de Servicios de Salud, en Reformas de Salud: Un análisis desde la perspectiva de equidad y ética. Centro Interamericano de Estudios en Seguridad Social. Documento de trabajo. Jornadas Internacionales en Economía de la Salud (2004), Iguazu, Brazil 13-16
3. Bobadilla J.L. Assessment issues. Closing the equity gap. Searching for essential health services in low and middle income countries. A review of recent studies on health priorities (1998), Interamerican Development Bank, Washington DC 25-43 No. Soc-106
4. Barcelo A., Aedo C., Rajpathak S., and Robles S. The cost of diabetes in Latin America and the Caribbean. Bull WHO 81 (2003) 19-27
5. Panamerican Health Organization. Hypertension affects in the continent. Working Paper (2004), PAHO, Washington DC 1-2
6. Elliot W. The costs of treating hypertension. what are the long-term realities of cost containment and pharmacoeconomics?. Hypertens Costs/Postgrad Med 99 (1996) 241-152
7. SSA. Boletín del Sistema Unico de Información Epidemiológica 16 (2004) 3-4
8. Calvo V. Nuevos retos del control de la hipertensión arterial. Rev Med del IMSS. Mexico 36 (1998) 199-201
9. Panamerican Health Organization. Health in the Americas-2002. Cardiovascular Diseases. Hypertension (2002), PAHO, Washington DC 115-123
10. SSA, IMSS, and ISSSTE. Boletín de Información Estadística. Casos de morbilidad hospitalaria por demanda específica, 1993-2002 (2004) 22-27 México, DF
11. Marteau S., and Perego L. Modelo de costos basado en la actividad aplicado a consultas por trazadores de enfermedades cardiovasculares. Sal Pub Mex 34 (2001) 32-40
12. Secretaría de Salud: Estadísticas Vitales de México. Tendencias de la Mortalidad por tipo de institución y causa específica. México, DF, Vol III, 2005:31-78.
13. Secretaría de Salud: Informe Técnico de Resultados de la Encuesta Nacional de Enfermedades Crónicas. México DF/DGE/Documento 12, 1998, pp 19-26.
14. Murray A. Statistical modelling and statistical inference: measurement error in the explanatory variables. Box-Jenkins technique. Statistical Modelling in GLIM (2000), National Coordinating Centre for Health Technology Assesme Oxford University Press, Oxford, New York 67-112
15. Eastman R.C., Javitt J.C., Dasbach E.J., Zbrozek A.S., Dong F., Manninen D., Garfield S.A., Copley-Merriman C., and Harris M. Model of complications of NIDDM. Diabetes Care 20 (1997) 725-735
16. Banco de México: Indice Nacional de Precios por Servicios Médicos en México. Cuadernos Mensuales, Base 1980=100. La Actividad económica en México. 1983-2004. Gerencia de Investigación Económica. 2004, Cap. 2, pp 35-68.
17. Wood P. Measuring the consequences of illness. World Health Stat Q 42 (1986) 115-121
18. World Health Organization. Guidelines to Assess the Social and Economic Impact Consequences of the Diseases (1990) 7-24 Geneva
19. Secretaría de Salud: Salud México. Prevención y control de enfermedades: programa para hipertensión arterial. México, DF, Vol. 1, 2004, pp 122-124.
20. Villarreal E., and Matew-Quiroz A. Costo de la atención de la hipertensión arterial y su impacto en el gasto en salud en México. Sal Pub Mex 44 (2002) 7-13
21. García C., Thorogood M., Wonderling D., and Reyes S. Economic analysis of a pragmatic randomized trial of home visits by nurse to elderly people with hypertension in Mexico. Sal Pub Mex 44 (2002) 14-20
22. Edelson J.T., Weinstein M.C., and Tosteson A.N. Long-term cost-effectiveness of various initial monotherapies for mild to hypertension. J Am Med Assoc 263 (1990) 407-413
23. McMurray J. The health economics of the treatment of hyperlipidemia and hypertension. Am J Hypertens 12 (1999) 99-104
24. Chan B., Coyte P., and Heick C. Economic impact of cardiovascular disease in Canada. Can J Cardiol 10 (1996) 1000-1006
25. Joffres M.R. Awarness, treatment and control of hypertension in Canada. Am J Hypertens 10 (1997) 1097-1102
26. García C., Thorogood M., Reyes S., Salmerón J., and Durán C. The prevalence and treatment of hypertension in elderly population. Sal Pub Mex 4 (2001) 415-420
27. Secretaría de salud: Encuesta Nacional de Enfermedades Crónicas: Hipertensión. Tercera Edición, SSA, Mexico DF, 1996, pp 86-91.
28. National Institutes of Health. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (2003), National Instititutes of Health, Bethesda, MD 19-23 NIH Publication No. 03-5333
29. Shulman N., Martinez B., Brogan D., Carr A., and Miles C. Financial costs as an obstacle to hypertension therapy. Am J Public Health 76 (1986) 1105-1108
30. Huttin C., Moeller J., and Stafford R. Patterns and costs for hypertension treatment in the United States. clinical, lifestyle and socioeconomic predictors from the 1987 National Medical Expenditures Survey. Clin Drug Invest 20 (2000) 181-195